Rocket Lab Stock Surges on Record Launch Deal and Citi 'Buy' Rating

Rocket Lab (NASDAQ: RKLB) shares surged in morning trading, propelled by the announcement of a landmark launch contract and a new bullish rating from a major Wall Street firm. The stock was trading up more than 6% amid a flurry of positive corporate and market developments.

Key Catalysts

The primary driver behind the rally is a 20-mission agreement with Tokyo-based Earth observation firm Synspective, which Rocket Lab described as its largest-ever commercial launch contract for its Electron rocket. According to the company, the deal pushes its total launch backlog above 100 missions for the first time and provides multi-year revenue visibility through 2031.

Adding to the positive sentiment, analysts at Citi initiated coverage on Rocket Lab stock with a Buy rating and a $105 price target. The firm's endorsement, which cited the company's proven launch record and growing commercial pipeline, provided a fresh institutional catalyst for the shares.

Supporting Factors and Market Context

Ad

Several other developments are supporting the stock's advance. The company recently secured regulatory approval for its acquisition of Mynaric AG, a laser communications technology specialist, a move that broadens its space systems portfolio and strengthens its vertical integration strategy.

This corporate news is amplified by strong underlying fundamentals and institutional interest. In its most recent quarterly report, Rocket Lab posted revenue of $234 million, a 62% year-over-year increase, with a record backlog of $2.36 billion. Separately, ARK Invest disclosed the purchase of over 233,000 RKLB shares in the prior session.

A favorable macro environment is also providing a tailwind, with the Nasdaq Composite trading up more than 1.6%. This broad risk-on appetite in the market tends to benefit high-growth technology stocks like Rocket Lab.